X-86514374-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_053281.3(DACH2):c.623G>A(p.Gly208Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000563 in 1,207,505 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 24 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000072 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.000055 ( 0 hom. 22 hem. )
Consequence
DACH2
NM_053281.3 missense
NM_053281.3 missense
Scores
1
13
3
Clinical Significance
Conservation
PhyloP100: 6.65
Genes affected
DACH2 (HGNC:16814): (dachshund family transcription factor 2) This gene is one of two genes which encode a protein similar to the Drosophila protein dachshund, a transcription factor involved in cell fate determination in the eye, limb and genital disc of the fly. The encoded protein contains two characteristic dachshund domains: an N-terminal domain responsible for DNA binding and a C-terminal domain responsible for protein-protein interactions. This gene is located on the X chromosome and is subject to inactivation by DNA methylation. The encoded protein may be involved in regulation of organogenesis and myogenesis, and may play a role in premature ovarian failure. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DACH2 | NM_053281.3 | c.623G>A | p.Gly208Glu | missense_variant | 3/12 | ENST00000373125.9 | NP_444511.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DACH2 | ENST00000373125.9 | c.623G>A | p.Gly208Glu | missense_variant | 3/12 | 1 | NM_053281.3 | ENSP00000362217.4 |
Frequencies
GnomAD3 genomes AF: 0.0000717 AC: 8AN: 111525Hom.: 0 Cov.: 23 AF XY: 0.0000593 AC XY: 2AN XY: 33709
GnomAD3 genomes
AF:
AC:
8
AN:
111525
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
33709
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000390 AC: 7AN: 179311Hom.: 0 AF XY: 0.0000156 AC XY: 1AN XY: 64141
GnomAD3 exomes
AF:
AC:
7
AN:
179311
Hom.:
AF XY:
AC XY:
1
AN XY:
64141
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000547 AC: 60AN: 1095930Hom.: 0 Cov.: 29 AF XY: 0.0000609 AC XY: 22AN XY: 361412
GnomAD4 exome
AF:
AC:
60
AN:
1095930
Hom.:
Cov.:
29
AF XY:
AC XY:
22
AN XY:
361412
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000717 AC: 8AN: 111575Hom.: 0 Cov.: 23 AF XY: 0.0000592 AC XY: 2AN XY: 33769
GnomAD4 genome
AF:
AC:
8
AN:
111575
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
33769
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 02, 2023 | The c.623G>A (p.G208E) alteration is located in exon 3 (coding exon 3) of the DACH2 gene. This alteration results from a G to A substitution at nucleotide position 623, causing the glycine (G) at amino acid position 208 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;D;.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;M;.;.
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D;.
REVEL
Uncertain
Sift
Uncertain
D;D;D;.
Sift4G
Benign
T;T;D;D
Polyphen
D;D;.;.
Vest4
MVP
MPC
0.63
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at